The DOI matches its Crossref record; 192 of the 198 references it cites were found in a registry or an index.
Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism and novel therapeutic strategies for effective management
Open accessAbstract
homeostasis, autophagy, the release of nitric oxide and inflammatory mediators and altered gene and protein expression that involved apoptosis. Dox also causes downregulation of DNA methyltransferase 1 (DNMT1) enzyme activity which leads to a reduction in the DNA methylation process. This hypomethylation causes dysregulation in the mitochondrial genes like peroxisome proliferator-activated receptor-gamma coactivator (PGC)-1-alpha (PGC-1α), nuclear respiratory factor 1 (NRF-1) and mitochondrial transcription factor A (TFAM) unit in the heart. Apart from DNA methylation, Dox treatment also alters the micro RNAs levels and histone deacetylase (HDAC) activity. Therefore, in the current review, we have provided a detailed update on the current understanding of the pathological mechanisms behind the well-known Dox-induced cardiotoxicity. Further, we have provided some of the most plausible pharmacological strategies which have been tested against Dox-induced cardiotoxicity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The cumulative anthracycline dose is a major risk factor for severe cardiomyopathy development but young age at treatment, female sex, peak drug exposure and additional stress to the heart have also been implicated 161,162,163 .”
From Osteosarcoma (2022) · cites this paper as [163]
Citations
Cites
2 retracted
Suliman, H. B., Carraway, M. S., Ali, A. S., Reynolds, C. M., Welty‐Wolf, K. E., & Piantadosi, C. A. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32967 · Cited by 261
RetractedChoi, H. C., Song, P., Xie, Z., Wu, Y., Xu, J., Zhang, M., Dong, Y., Wang, S., Lau, K., & Zou, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803020200 · Cited by 85
RetractedAn integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072
Minotti, G., Menna, P., Salvatorelli, E., Cairo, G., & Gianni, L. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.2.6 · Cited by 3,868
DNA methylation landscapes: Provocative insights from epigenomics
Suzuki, M. M., & Bird, A. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2341 · Cited by 3,039
The ENCODE (ENCyclopedia Of DNA Elements) Project
(2004) · Science · doi:10.1126/science.1105136 · Cited by 2,390
Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells
Lister, R., Pelizzola, M., Kida, Y. S., Hawkins, R. D., Nery, J. R., Hon, G. C., Antosiewicz‐Bourget, J., O’Malley, R. C., Castanon, R., Klugman, S. A., et al. (2011) · Nature · doi:10.1038/nature09798 · Cited by 1,595
Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
Octavia, Y., Tocchetti, C. G., Gabrielson, K. L., Janssens, S. P., Crijns, H. J. G. M., & Moens, A. L. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.03.006 · Cited by 1,425
Nitric Oxide Synthases: Properties and Catalytic Mechanism
Griffith, O. W., & Stuehr, D. J. (1995) · Annual Review of Physiology · doi:10.1146/annurev.ph.57.030195.003423 · Cited by 1,311
Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation
Ichikawa, Y., Ghanefar, M., Bayeva, M., Wu, R., Khechaduri, A., Prasad, S. V. N., Mutharasan, R. K., Naik, T. J., & Ardehali, H. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72931 · Cited by 881
Research works printed but not linked: 6
- Gianni, 2008, Anthracycline cardiotoxicity: from bench to bedside, J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol., 26, 3777, 10.1200/JCO.2007.14.9401 · DOI
- Chustecka, 2006, Cardiotoxicity of imatinib is a" surprise, Nat. Med., 24
- Martínez-Mateo, 2017, Report of cisplatin-induced cardiotoxicity: a side effect to monitor closely, J. Heart Health, 3
- Speth, 1988, Clinical pharmacokinetics of doxorubicin, Clin. Pharmacokinet., 15, 15, 10.2165/00003088-198815010-00002 · DOI
- Youngson, 2006, Collins dictionary of human biology, Collins
- Zhu, 2009, Acute doxorubicin cardiotoxicity is associated with p53-induced inhibition of the mTOR pathway, Circulation, 119, 99, 10.1161/CIRCULATIONAHA.108.799700 · DOI
Cited by
Sorted by citations
Items 701–800 of 915
Yazdi, S. V. N., Zare‐Zardini, H., Miresmaeili, S. M., & Fesahat, F. (2022) · Iranian Journal of Breast Disease · doi:10.30699/ijbd.15.1.71 · Cited by 1
Potential protective effect of pitavastatin against doxorubicin-induced cardiotoxicity in male rats
(2023) · Journal of Population Therapeutics and Clinical Pharmacology · doi:10.47750/jptcp.2023.30.08.037 · Cited by 1
Acid-sensitive PEG-removable nanoscale liposomes for delivery of doxorubicin in A549/ADR therapy
Chen, H., Liu, C., Yu, S., Zhou, H., Shafiq, F., & Qiao, W. (2023) · New Journal of Chemistry · doi:10.1039/d3nj01764h · Cited by 1
Jatropha Tanjorensis attenuates doxorubicin-induced liver and spleen damages in rats
Usunobun, U., Agunu, O., & Okechukwu, B. (2024) · Journal of Research in Applied and Basic Medical Sciences · doi:10.61186/rabms.10.3.256 · Cited by 1
The Effects of Pediatric Acute Lymphoblastic Leukemia Treatment on Cardiac Repolarization
Lazar, D. R., Cainap, S. S., Lazăr, F.-L., Maniu, D., Blag, C. L., Bota, M., Colceriu, M.-C., & Zdrenghea, M. (2024) · Children · doi:10.3390/children11101158 · Cited by 1
Kalaiselvi, S., Arunachalam, S., Pichiah, P. B. T., Vasan, S. B., Venkateswaran, M. R., Siva, D., Gothandam, J., & Achiraman, S. (2024) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23855 · Cited by 1
Yücel, E., ZENGİN, M. N., Özmen, Ö., & Çiftçi, O. (2024) · OSMANGAZİ JOURNAL OF MEDICINE · doi:10.20515/otd.1552820 · Cited by 1
Ononiwu, C. P., Joshua, P. E., Amah, C. C., Asomadu, R. O., Okorigwe, E. M., Nnemolisa, S. C., Ezeorba, T. P. C., Nwanelo, V. O., Iyidiegwu, F. C., Duru, J. O., et al. (2024) · Laboratory Animal Research · doi:10.1186/s42826-024-00225-3 · Cited by 1
Omo-Erhabor, A. J., & Edosuyi, O. (2024) · Tropical Journal of Drug Research · doi:10.26538/tjdr/v1i1.4 · Cited by 1
Ifora, I., Adriani, S., & Suliana, N. (2025) · International Journal of Research Publication and Reviews · doi:10.55248/gengpi.6.0125.0638 · Cited by 1
Gao, Y. T., & Yang, S. (2025) · Drug and Chemical Toxicology · doi:10.1080/01480545.2025.2481873 · Cited by 1
Wang, J., Wang, W., Liu, B., Fan, X., Liu, S., Yang, G., Liu, J., Lu, T., & Chen, L. (2025) · Planta Medica · doi:10.1055/a-2615-7291 · Cited by 1
A bibliometric analysis of targeted therapy cardiotoxicity research in cancer patients (2004–2024)
Chen, G., Chen, G., Zhou, H., Yang, Q., Shang, Y., Qin, R., Hou, Y., Zhang, C., Lin, J., Ye, X., et al. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1593178 · Cited by 1
Research Progress on Nano Delivery Systems of Doxorubicin
Wen, L., & Xiong, X. Y. (2025) · Particle & Particle Systems Characterization · doi:10.1002/ppsc.202500049 · Cited by 1
Exosomes shape inflammatory tumor microenvironment
He, C., Yu, W., Zhao, Q., Liu, H., Wang, Y., Xiong, Y., Zeng, Y., Zhao, J., Xu, Z. P., & Zhang, L. L. (2025) · Chinese Chemical Letters · doi:10.1016/j.cclet.2025.111900 · Cited by 1
Rajapandiyan, U., Kumar, M. R., Manikandan, H., & Sivakumar, K. (2025) · Future Medicinal Chemistry · doi:10.1080/17568919.2025.2570968 · Cited by 1
Heart failure and cancer: From active exposure to passive adaption
Du, Y., & Wu, T. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.992011 · Cited by 1
Waziri, B. I., Wali, N., & Salisu, A. I. (2023) · Advances in Biomedical and Health Sciences · doi:10.4103/abhs.abhs_2_23 · Cited by 1
Harutyunyan, T. A. (2023) · Proceedings of the YSU B Chemical and Biological Sciences · doi:10.46991/pysu:b/2023.57.1.032 · Cited by 1
Lérida‐Viso, A. (2023) · RiuNet (Universitat Politècnica de València) · doi:10.4995/thesis/10251/194709 · Cited by 1
Asar, T. O., Nadeem, M. S., Al-Abbasi, F. A., Sheikh, R. A., Naqvi, S., Hosawi, S. B. I., Almalki, N. A. R., Alhayyani, S., Kumar, V., Rizwanuddin, S., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3209248/v1 · Cited by 1
INKing the Cardiotoxicity Out of Doxorubicin
Guo, Z., & Javaheri, A. (2023) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2023.05.001 · Cited by 1
Wu, L., Qin, Y., Zheng, X., Zhang, G., Zhou, Q., & Liu, L. (2025) · Research Square · doi:10.21203/rs.3.rs-5713487/v1 · Cited by 1
Sildenafil aggravates adriamycin-induced testicular toxicity in rats; a preliminary investigation
Adeyanju, A. A., Oyenihi, O. R., Oguntibeju, O. O., & Ojomu, O. (2021) · Drug and Chemical Toxicology · doi:10.1080/01480545.2021.2018455
Wang, X., Ling, G., WeiLi, L. I., Wei, W. A. N. G., & Wang, Y. (2022) · Scientia Sinica Vitae · doi:10.1360/ssv-2021-0406
Santos, T. L., Parreira, W. D. S. P., Júnior, J. A. F., de Moraes, J. B., Diniz, W. K. V., Fernandes, J. G. F., Moura, M. D. L. B., Nunes, E. M., & Andrade, A. C. B. A. (2022) · Research Society and Development · doi:10.33448/rsd-v11i9.31830
Can Exercise Training Prevent Doxorubicin-induced Cardiomyopathy?
Machado, M. V. R., Chapuis, R. J. J., & Vieira, A. B. (2022) · International Journal of Cardiovascular Sciences · doi:10.36660/ijcs.20220170
Metwaly, A., Enein, A. A. N., Abd-Allah, A., & Hanafy, E. A. (2022) · Egyptian Journal of Chemistry · doi:10.21608/ejchem.2022.156362.6766
Bioactive Compounds from Curcuma amada and Their Effect on Acute Myeloid Leukemia
Chandran, A., Jayasankar, V., Spagnuolo, P. A., & Subramanian, J. (2022) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.2023047542
Metwally, R., Salem, M. Y., fatah, A. S. A., & mohamady, R. (2023) · Benha Medical Journal · doi:10.21608/bmfj.2023.188421.1753
Akhtari, N., Tafizi, F., & Naseh, V. (2023) · Research Square · doi:10.21203/rs.3.rs-2990121/v1
Uterine effects of Chemotherapy and Preventive Methods
Taner, M. Z., & Kaplanoğlu, G. T. (2023) · Türk Üreme Tıbbı ve Cerrahisi Dergisi · doi:10.24074/tjrms.2023-97020
He, Y., Yu, Z., Schomann, T., Zhang, H., Eich, C., & Cruz, L. J. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.18.545497
The Effect of Oral Andrographolide on Cardiac Biomarkers in Doxorubicin-induced Rats
Hanifah, S., Arozal, W., & Juniantito, V. (2023) · Journal Of Medicine & Health · doi:10.28932/jmh.v5i2.5026
Cardiotoxicity of Chemotherapy in Lynch Syndrome – A Literature Review
Vîlceleanu, B.-V., Voinea, O. C., Buzilă, C. A., Ciobanu, D., Stan, L., & Dumitrescu, S. I. (2023) · Romanian Journal of Military Medicine · doi:10.55453/rjmm.2023.126.5.1
Kim, M., Choi, H., Park, S., Lee, J.-I., & Lee, J. (2023) · Molecules · doi:10.3390/molecules28248090
Afiansyah, A. G., Mardianto, R., & Salmasfattah, N. (2023) · Jurnal Riset Kesehatan Poltekkes Depkes Bandung · doi:10.34011/juriskesbdg.v16i1.2484
Basini, J., & Mallavarapu, V. (2023) · IP International Journal of Comprehensive and Advanced Pharmacology · doi:10.18231/j.ijcaap.2023.040
Soliman, N. A., Dahmy, S. I. E., Shalaby, A. A., & Mohammed, K. A. (2024) · Research Square · doi:10.21203/rs.3.rs-3826623/v1
Al-Gholam, M. A.-S., Hathout, H. M. R., Safwat, M. M., & Essawy, A. S. (2024) · Anatomy & Cell Biology · doi:10.5115/acb.23.247
Anti-apoptotic effects of minocycline on doxorubicin-induced cardiotoxicity in male Wistar rats
Piri, H., Aali, E., Hedayati, S. K., Shahbaz, S. K., & Naderi, Y. (2023) · Scientific Journal of Kurdistan University of Medical Sciences · doi:10.61186/sjku.28.5.13
Mohsin, H. A., Qazzaz, M. E., & Alfahad, M. A. (2023) · Al-Mağallaẗ al-ʻirāqiyyaẗ li-l-ṣaydalaẗ · doi:10.33899/iphr.2023.140439.01046
The Importance of Mitochondrial H2o2 in Doxorubicin-Induced CardiotoxicityPreprint
Park, J. W., Kim, M. Y., Jang, S. Y., Lee, B., & Chang, T. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4818947
The Cardio-protective Effect of Water-Soluble Vitamins on Anticancer Drug-Induced Cardiotoxicity
Gaeta, R., Izaguirre, S., & Shah, A. K. (2024) · Advances in biochemistry in health and disease · doi:10.1007/978-3-031-55474-2_1
Zaki, M. M., El-Sayed, I. H., Abdel‐Mogib, M., El‐Shehawy, A. A., & El-Khawaga, O. Y. (2024) · PubMed Central · doi:10.22038/ajp.2024.24101
Robust G‐Quadruplex Dimer‐Guided Transmembrane DNA Nanovehicles for Targeted Payload Delivery
Liu, C., Wang, Q., Shi, L., & Li, T. (2024) · Analysis & Sensing · doi:10.1002/anse.202400048
Nutraceuticals in Cardiovascular Diseases and their Associated Risk Conditions
(2024) · Frontiers research topics · doi:10.3389/978-2-8325-5442-5
Soliman, N. A., Dahmy, S. I. E., Shalaby, A. A., & Mohammed, K. A. (2024) · Research Square · doi:10.21203/rs.3.rs-4993212/v1
Toxicology of daunomycin: A logical approach to risk assessment and management
Kumar, N., & Thapliyal, P. C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95235-4.00023-2
Li, Y., Fan, L., Wang, X., Zuo, Y., Liu, Y., & Lv, S. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e38544
RetractedLemos, J. D. A., Miranda, S. E. M., Oliveira, M. L. G., Cassali, G. D., Ferreira, L. A. M., Oliveira, A. E. M. D. F. M., & de Barros, A. L. B. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106317
Siri‐Angkul, N., Chattipakorn, S. C., & Chattipakorn, N. (2024) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815223910124090006
Novel and conventional formulations of doxorubicin as a key anticancer agent: a literature review
Kunachowicz, D., Kłosowska-Buryło, K., Konarska, D., & Kepinská, M. (2024) · Farmacja Polska · doi:10.32383/farmpol/194456
Carcinoma de células renais sólido em cão
Santos, L. M. F. D. A., de Bem, G. K., Mazaro, R. D., & Martinez‐Pereira, M. A. (2024) · ACTA SCIENTIAE VETERINARIAE · doi:10.22456/1679-9216.139521
Koszelska, K., Wypych, M., Kciuk, M., Guziejewski, D., Metelka, R., & Smarzewska, S. (2025) · Electroanalysis · doi:10.1002/elan.12030
Reviews in Cardiovascular Pharmacology: 2023
(2025) · Frontiers research topics · doi:10.3389/978-2-8325-6052-5
CAFFEINE EFFECT ON ECHOCARDIOGRAPHY PARAMETERS IN RATS WITH DOXORUBICIN-INDUCED CARDIOMYOPATHYS
Mukvych, V. V., & Севериновська, О. В. (2025) · Bulletin of Problems Biology and Medicine · doi:10.29254/2077-4214-2025-1-176-251-260
ROS Signaling Controls Lipid Accumulation in HepG2 Cells Driven by Doxorubicin-Induced Senescence
Yun, C., Noh, S. J., Zahrani, H. K., Kim, S. H., & Jung, Y. (2025) · Drug Targets and Therapeutics · doi:10.58502/dtt.24.0020
A Case of Acute Right Heart Failure With Severe Pulmonary Hypertension Associated With Doxorubicin
Saravia, S. D., & Sahni, G. (2025) · Annals of Internal Medicine Clinical Cases · doi:10.7326/aimcc.2024.0576
Precision health and medicine in cardio-oncology
Lee, J. G., & Sun, L. Y. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29829-5.00022-0
Özgermen, B. B., Haydardedeoğlu, A. E., & Yavuz, O. (2025) · Acta veterinaria · doi:10.2478/acve-2025-0012
He, Q., Abulaiti, R., Feng, X., Tian, L., & Wang, K. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152275
Hassan, S. L., & Chatha, D. E. (2025) · Cureus · doi:10.7759/cureus.87604
Roles of Non-Coding RNA in Anthracycline Cardiotoxicity: A Narrative Review
Xiao, S., Li, Y. R., Li, B., Wang, H., Wang, K., & Yang, S. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s526611
Zhu, Y., He, J., & Wei, R. (2025) · Current Medicinal Chemistry · doi:10.2174/0109298673401752250709101602
Shahgordi, S., Nosratzadeh, N., Kaffash, E., Dehestani, S., Ansari, B., Marouzi, S., Abbaspour, M., & Hashemi, M. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.107304
Doxorubicin-Induced Cardiomyopathy: Molecular Mechanisms and Emerging Therapeutic Strategies
Tarannum, M., Goel, R., & Kumar, R. (2025) · International Journal of Newgen Research in Pharmacy & Healthcare · doi:10.61554/ijnrph.v3i1.2025.146
Doxorubicin-Induced Cardiotoxicity at Non-Cumulative Dose in a Dog with Multicentric Lymphoma
Go, J., Ahn, S., Heo, S., Hwang, S., Ryu, H., Park, J., Shin, C., Jung, D., Yu, D., & Bae, H. (2025) · Journal of Veterinary Clinics · doi:10.17555/jvc.2025.42.4.190
Демянчук, Н., & Пазюк, Л. (2025) · Перспективи та інновації науки · doi:10.52058/2786-4952-2025-8(54)-2123-2138
Yazid, M., Lnu, M., Koesnoe, S., Rinaldi, I., Winston, K., & Putra, D. (2025) · Cureus · doi:10.7759/cureus.91632
Nontraditional Models for Acute Kidney Injury Research: Organoids, Zebrafish, and More
Jog, E., Wu, T., Maggiore, J. C., & Hukriede, N. A. (2025) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2025.151668
Li, J., Zhong, Z.-L., Tang, J. Y., Chen, Y., Xiang, C.-P., Li, J., Tian, J., Luo, X., Jian-jie, Z., & Tian, Y. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08617-w
Osuji, E., Wright, J. L., Brar, T., Scott, S. S., & Smith, S. A. (2025) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-3-031-97517-2_6
Phytochemicals in Cardioprotection and Cardiotoxicity
Scott, S. S., Albers, C., Iqbal, M., Ailemen, I., Smith, S. A., & Parinandi, N. L. (2025) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-3-031-97517-2_4
Doxorubicin Induced Mitochondrial Dysfunction and Cardiotoxicity
Bhullar, S. K., Thingnam, R., Rabinovich-Nikitin, I., & Kirshenbaum, L. A. (2025) · Advances in biochemistry in health and disease · doi:10.1007/978-3-031-90598-8_17
Impact of Cardiotoxicity on Cardiac Bioenergetics
Young, M., & Aksentijević, D. (2025) · Advances in biochemistry in health and disease · doi:10.1007/978-3-031-90598-8_5
Pelayanan Kefarmasian: Konsep, Praktik, dan Peran Apoteker
Mayefis, S. F. A. D., Wardhani, M. C. P. A. F. A., Marseli, M. C. P. A. C., Aqsa, M. F. A. K. D., Wirastuti, S. F. A. A., Hartina, Anisya, S. F. A. K., apt. Hery Diar Febryanto, S. F., Naki, S. F. A. M. I., Filliana, M. C. P. A. U., et al. (2025) · doi:10.57207/632483
Şevgin, K., Çelik, Y., TOMBUL, N. E., & Vuruşkan, A. K. (2025) · İnönü Üniversitesi Sağlık Hizmetleri Meslek Yüksek Okulu Dergisi · doi:10.33715/inonusaglik.1696064
Ifora, I., & Oktavia, S. (2025) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2025.00701
Induced Pluripotent Stem Cell-Derived Cardiac Cells in Advancing Cardiovascular Medicine
Wasserman, A. H., Abolibdeh, B., Montalvo, N., & Hong, C. C. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-15734-9.00075-3
Walker, V. E., Bansal, N., Torres, S. M., Stevenson, K. E., Flamand, Y., Walker, D. M., Sallan, S. E., & Lipshultz, S. E. (2025) · Cardio-Oncology · doi:10.1186/s40959-025-00396-5
Novel Oncologic Strategies in Osteosarcoma Management: Maximizing Impact, Minimizing Harm
Dohadwala, T. K., Abbas, R. H., Siji, S. M., Nadar, S., Sakina, S., Jairath, N., Patel, H. A., & Zurashvili, T. (2025) · Discoveries · doi:10.15190/d.2025.15
He, X., Huo, X., Zhang, J., & Li, X. (2025) · Toxicology Research · doi:10.1093/toxres/tfaf160
Guilbeau‐Frugier, C., Karsenty, C., Ghenghea, R., Cauquil, M., Lachaize, V., Pataluch, N., Lairez, O., Dague, É., Séverac, C., Sénard, J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.05.692508
Almazloum, A., Maharsy, W. M., Dostie, S., Becerril-Jiménez, F., Eymard, C., Komati, H., Leblanc, L., Manchoju, A., Mochirian, P., Zelli, R., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c01999
Edosuyi, O., Osagiede, E. B., Eguasa, N., Ayodele, S. O., Eunice, E. A., Ojonugba, E. R., Edosuyi, V., Elekofehinti, O. O., Omo-Erhabor, A. J., & Igbe, I. (2025) · Prospects in Pharmaceutical Sciences · doi:10.56782/pps.677
NRF2 upregulation by CDDO-Me protects AC16 human cardiomyocytes against doxorubicin-induced toxicity
Roberts, J. A., Batie, M., Ponsford, A. H., Poh, J., Hewitt, B. J., Botfield, H. F., Hill, L. J., Sanderson, C. M., Rocha, S., & Sharma, P. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118878
Ye, C., Yan, C., Bian, S., Li, X.-R., Li, Y., Wang, K.-X., Zhu, Y.-H., Wang, L., Wang, Y.-C., Wang, Y.-Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26488302
Zhu, W., Lian, N., Wang, J., Zhao, F., Liu, B., Sheng, J., Zhang, C., Zhou, X., Wenbai, G., Xie, C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26043670
Oudot, A., Courteau, A., Guillemin, M., Vrigneaud, J., WALKER, P. M., Brunotte, F., Cochet, A., & Collin, B. (2021) · Figshare · doi:10.6084/m9.figshare.16649975
Chu, J., Tung, L., Attalah, I., Wei, C., Cobleigh, M., Rao, R. D., Feinstein, S. B., Usha, L., Banach, K., Reiser, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25001686
Shen, C., Yang, B., Huang, L., Chen, Y., Zhao, H., & Zhu, Z. (2023) · Figshare · doi:10.6084/m9.figshare.22600799
Misiak, P., Niemirowicz-Laskowska, K., Markiewicz, K. H., Wielgat, P., Kurowska, I., Czarnomysy, R., Misztalewska‐Turkowicz, I., Car, H., Bielawski, K., & Wilczewska, A. Z. (2024) · Figshare · doi:10.6084/m9.figshare.26576246
Additional file 1 of Bento: a toolkit for subcellular analysis of spatial transcriptomics data
Mah, C. K., Ahmed, N., Lopez, N. A., Lam, D. C., Pong, A., Monell, A., Kern, C., Han, Y., Prasad, G., Cesnik, A. J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25530351
Additional file 2 of Bento: a toolkit for subcellular analysis of spatial transcriptomics data
Mah, C. K., Ahmed, N., Lopez, N. A., Lam, D. C., Pong, A., Monell, A., Kern, C., Han, Y., Prasad, G., Cesnik, A. J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25530473
Biomarkers for Early Detection of Doxorubicin-Induced Cardiotoxicity: A Focus on miRNAs and EXOs
Iyer, A., & Sayyed, M. (2025) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2025.00653
Jolfayi, A. G., Montazeri, S., Poopak, A., Soheili, A., Tavakoli, A. M., Salmanipour, A., Adimi, S., & Rezaei-Kalantari, K. (2025) · Springer eBooks · doi:10.1007/978-981-95-0313-1_8
Yohanes Arvi, A. W. (2025) · Vascular and Endovascular Review · doi:10.64149/j.ver.8.19s.276-282
Rab, S. O., AlKhafaje, Z., Hussein, U. A.-R., Adel, Z., Alkadir, O. K. A., Aldulaimi, A., Saeed, S. M., Taher, W. M., Alwan, M., & Smerat, A. (2025) · Cardiovascular Toxicology · doi:10.1007/s12012-025-10078-4
Ngurah Arie Kapindra Dharma, A. W. (2025) · Vascular and Endovascular Review · doi:10.64149/j.ver.8.20s.19-23
Metadata
- Authors
- Rawat, P. S., Jaiswal, A., Khurana, A., Bhatti, J. S., & Navik, U.
- Affiliations
- Central University of Punjab (IN)
- P.V. Narsimha Rao Telangana Veterinary University (IN)
- Venue
- Biomedicine & Pharmacotherapy
- Publisher
- Elsevier BV
- Published
- 2021-07
- Volume
- 139
- Pages
- 111708
- ISSN
- 0753-3322 (ISSN-L)
- OpenAlex
- W3160992829
- Cited by
- 909
- References
- 198
- Citations by year
- 2026: 171 · 2025: 232 · 2024: 208 · 2023: 193 · 2022: 92 · 2021: 13
- FWCI
- 24.68
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Biomedicine & Pharmacotherapy (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Royal Society of Medicine
- University of Central Punjab (GP-25)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Chemotherapy-induced cardiotoxicity and mitigation
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- doxorubicin, cardiotoxicity, molecular mechanisms, DNA methylation, DNMT1, mitochondrial dysfunction, PGC-1α, NRF1, TFAM, microRNA, histone deacetylase, autophagy, apoptosis, nitric oxide, inflammatory mediators, cardioprotection, anthracycline chemotherapy
- MeSH terms
- Animals, Antibiotics, Antineoplastic, Doxorubicin, Humans, Mitochondria, Heart, Apoptosis, Oxidative Stress, Cardiotoxicity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review